Xi Wang

Xi Wang has almost three decades experience with a rare combination of clinical, research, business and medical affairs experiences in both small and large biopharmaceutical industry settings, with specialties including in COPD, Asthma and IPF, CardioMetabolic Diseases, hypertension and bronchoconstrictive diseases, and cardiac physiology, pharmacology and pathology.

She has a comprehensive understanding of healthcare systems and PhRMA code; Strong ability to interact with national and regional key opinion leaders (KOLs), academic investigators, individual healthcare providers, organized customer, payers and internal team members.

Her career highlights include: Medical Director, Field Group, Pfizer; Senior Medical Science Liaison, Sanofi Genzyme; Senior Medical Science Liaison, Mallinckrodt Pharmaceuticals; and Associate Director, Health Science Executive, Boehringer Ingelheim Pharmaceuticals.

She is Bilingual: fluent in English and Mandarin.